November 30, 2017
Orexo publishes prospectus and applies for listing of bonds on Nasdaq Stockholm
Media
November 28, 2017
Onxeo Establishes Scientific Advisory Board with International Experts in DNA-targeting
November 23, 2017
Wilson Therapeutics AB (publ) Interim Report January 1–September 30, 2017
November 22, 2017
First patients enter TARGET study, recently initiated by Cerenis Therapeutics to evaluate HDL nanoparticles in patients with esophageal cancer
November 22, 2017
Nordic Nanovector Capital Markets Day 2017
November 22, 2017
Nordic Nanovector ASA – Results for the Third Quarter 2017
November 20, 2017
Zubsolv® receives authorization for treatment of opioid dependence in Europe
November 16, 2017
Wilson Therapeutics to host conference call to provide third quarter 2017 business update
November 14, 2017
Strongbridge Biopharma plc Provides Corporate Update and Reports Third Quarter 2017 Financial Results
November 14, 2017
Bonesupport – Cerament® G’s potential to prevent and manage biofilm-related bone infections highlighted in new high-profile publication
